about
Glutamine promotes ovarian cancer cell proliferation through the mTOR/S6 pathway.The expression of platelet-activating factor receptor modulates the cisplatin sensitivity of ovarian cancer cells: a novel target for combination therapy.Multiple blocks in the engagement of oxidative phosphorylation in putative ovarian cancer stem cells: implication for maintenance therapy with glycolysis inhibitors[Ovarian tumors in postmenopausal women: report of 100 cases and review of the literature]Identification of a peptide specifically targeting ovarian cancer by the screening of a phage display peptide libraryMiR-1271 Inhibits Ovarian Cancer Growth by Targeting Cyclin G1.MiR-494 Inhibits Epithelial Ovarian Cancer Growth by Targeting c-Myc.Epigenetics changes caused by the fusion of human embryonic stem cell and ovarian cancer cells.Novel approach for the detection of intraperitoneal micrometastasis using an ovarian cancer mouse model.Pharmacology and toxicology of the novel investigational agent Cantrixil (TRX-E-002-1)Ovarian cancer patients at high risk of BRCA mutation: the constitutional genetic characterization does not change prognosis.Analysis of long non-coding RNA expression profiles in ovarian cancerMetformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.Upregulation of miR-520b promotes ovarian cancer growth.Preferential effect of akt2-dependent signaling on the cellular viability of ovarian cancer cells in response to EGF.Extremely long tumor retention, multi-responsive boronate crosslinked micelles with superior therapeutic efficacy for ovarian cancer.Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)4]PF6 and [Au(P)4]PF6 (P = thp or PTA) Anticancer Complexes.Association between circadian gene CLOCK and cisplatin resistance in ovarian cancer cells: A preliminary study.Prognostic factors in epithelial ovarian cancer: A population-based study.
P2860
Q30371587-B8E07692-DCF2-4456-A9F0-FF8512BA0D47Q33994379-0A2FFCD0-52AD-4912-AEDA-A051EF0D3508Q34483738-A94B0AAD-447E-4B22-8291-2CD367CDDE88Q35226267-E790DD9A-6E39-43B6-8981-A81F87C8619AQ36055188-9F7E1F62-095C-4F1B-AE2C-7AECEAB71B93Q36197033-61BFE368-59BB-48A1-A4AB-EBBD52522B71Q36623848-713321AF-6F63-4522-922F-247BBB10639FQ37260961-93E4F64B-89CC-4CE1-8FC7-FC054F90F007Q37604850-0072A5EE-F1D8-4287-AB45-B7791AF5E5DDQ37639235-6C83B2F3-FE22-43DD-AC8B-A1ADC9663D7FQ40035188-CFC62552-1FFC-4433-BE53-023695F81D2CQ41142365-F055B2CD-4C8C-4CA2-B5B0-43A67B7B738BQ41143859-6171A47D-7179-4B78-B0AA-AD9689C0FBD6Q41615311-99BAC3E0-1B81-42DD-A361-B252F4CC38E3Q42914388-F7E5C032-AF38-448A-9991-7485795D8F0BQ46342071-CD970296-11D3-4F47-BF23-F797D203D85BQ47712025-9AE23D50-5F60-4FCE-8C99-F328B88817A6Q55044842-909BD5B7-9B8D-4537-AF0B-2D377ED0858CQ55315651-5FDBD8A0-576E-487D-A409-1DADA87DF5A3
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Ovarian cancer: risk factors, treatment and management.
@en
type
label
Ovarian cancer: risk factors, treatment and management.
@en
prefLabel
Ovarian cancer: risk factors, treatment and management.
@en
P2860
P1476
Ovarian cancer: risk factors, treatment and management.
@en
P2093
Carolyn Rooth
P2860
P304
P356
10.12968/BJON.2013.22.SUP17.S23
P577
2013-09-01T00:00:00Z